BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25487133)

  • 1. Mexican consensus on the diagnosis and management of hepatocellular carcinoma.
    González Huezo MS; Sánchez Ávila JF; ; ; ; ; ;
    Rev Gastroenterol Mex; 2014; 79(4):250-62. PubMed ID: 25487133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presentation, staging, and outcome of patients with hepatocellular carcinoma at a center in Veracruz, Mexico].
    Martinez-Mier G; Esquivel-Torres S; Medina Granados JP; Luna-Castillo M; Castillo-Chiquete R; Calzada-Grijalva JF; Gonzalez-Velazquez F
    Rev Gastroenterol Mex; 2014; 79(3):171-9. PubMed ID: 25236795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular carcinoma. Experience at the Instituto Nacional de Cancerología].
    Mondragón Sánchez R; Ochoa Carrillo FJ; Ruiz Molina JM; Herrera Goepfer R; Oñate Ocaña LF; Aiello Crocifoglio V
    Rev Gastroenterol Mex; 1997; 62(1):34-40. PubMed ID: 9190651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma and hepatitis C in Mexico.
    Mondragón-Sánchez R; Garduño-López AL; Hernández-Castillo E; Gómez-Gómez E; Ruiz-Molina JM
    Hepatogastroenterology; 2005; 52(64):1159-62. PubMed ID: 16001652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of hepatocellular carcinoma in Mexico.
    Cisneros-Garza LE; González-Huezo MS; López-Cossio JA; Kuljacha-Gastelum AL
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(3):223-227. PubMed ID: 29801665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Practice guideline for diagnosis and treatment of hepatocellular carcinoma].
    Park JW;
    Korean J Hepatol; 2004 Jun; 10(2):88-98. PubMed ID: 15218342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian recommendations for the management of hepatocellular carcinoma: a consensus statement.
    Lubel JS; Roberts SK; Strasser SI; Thompson AJ; Philip J; Goodwin M; Clarke S; Crawford DH; Levy MT; Shackel N
    Med J Aust; 2021 Jun; 214(10):475-483. PubMed ID: 33314233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice manual proposed by the Japan Society of Hepatology.
    Kudo M; Okanoue T;
    Oncology; 2007; 72 Suppl 1():2-15. PubMed ID: 18087177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers.
    Rodríguez de Lope C; Reig M; Matilla A; Ferrer MT; Dueñas E; Mínguez B; F Castroagudín J; Ortiz I; Pascual S; Lledó JL; Gallego A; Arenas JI; Aracil C; Forne M; Muñoz C; Pons F; Sala M; Iñarrairaegui M; Martin-Llahi M; Andreu V; Garre C; Rendón P; Fuentes J; Crespo J; Rodríguez M; Bruix J; Varela M;
    Med Clin (Barc); 2017 Jul; 149(2):61-71. PubMed ID: 28279536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progression of hepatitis B- and C-infections to chronic liver disease and hepatocellular carcinoma: presentation, diagnosis, screening, prevention, and treatment of hepatocellular carcinoma.
    Hayashi PH; Di Bisceglie AM
    Med Clin North Am; 2005 Mar; 89(2):345-69. PubMed ID: 15656930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment for hepatocellular carcinoma.
    Cahill BA; Braccia D
    Clin J Oncol Nurs; 2004 Aug; 8(4):393-9. PubMed ID: 15354926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective.
    Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
    Bräu N; Fox RK; Xiao P; Marks K; Naqvi Z; Taylor LE; Trikha A; Sherman M; Sulkowski MS; Dieterich DT; Rigsby MO; Wright TL; Hernandez MD; Jain MK; Khatri GK; Sterling RK; Bonacini M; Martyn CA; Aytaman A; Llovet JM; Brown ST; Bini EJ;
    J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
    García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V
    Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis.
    Cisneros-Garza LE; González-Huezo MS; Moctezuma-Velázquez C; Ladrón de Guevara-Cetina L; Vilatobá M; García-Juárez I; Alvarado-Reyes R; Álvarez-Treviño GA; Allende-Pérez S; Bornstein-Quevedo L; Calderillo-Ruiz G; Carrillo-Martínez MA; Castillo-Barradas M; Cerda-Reyes E; Félix-Leyva JA; Gabutti-Thomas JA; Guerrero-Ixtlahuac J; Higuera-de-la-Tijera F; Huitzil-Meléndez D; Kimura-Hayama E; López-Hernández PA; Malé-Velázquez R; Méndez-Sánchez N; Morales-Ruiz MA; Ruíz-García E; Sánchez-Ávila JF; Torrecillas-Torres L
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(2):216-234. PubMed ID: 35431142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of hepatocellular carcinoma].
    Pache I; Bize P; Halkic N; Montemurro M; Giostra E; Majno P; Moradpour D
    Rev Med Suisse; 2010 Jan; 6(233):198-202. PubMed ID: 20214192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma.
    Tholey DM; Ahn J
    Gastroenterol Clin North Am; 2015 Dec; 44(4):761-73. PubMed ID: 26600218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.